T Rowe Price Health Sciences Fund, Inc

100 East Pratt Street,
Baltimore , MD, 21202

Rank

Rank Universe
24 60

Summary

The fund seeks capital appreciation in the long term by investing in large-and mid-size companies in the United States.

The investment process is designed to highlight companies in the benchmark index that are engaged in the health sciences companies.

The process focuses on companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life scienc More

Link

Directors

Mar 12, 2024
  • Bruce W. Duncan
  • David Oestreicher
  • Eric L. Veiel
  • Kellye L. Walker
  • Mark J. Parrell
  • Melody Bianchetto
  • Paul F. McBride
  • Robert J. Gerrard, Jr.
  • Teresa Bryce Bazemore

Chief Compliance Officer

  • Armando Capasso

Fund Manager(s)

Price

  • $ 96.49 ( -0.98 )
    Oct 30, 2024
    Last Close
  • Net Assets
  • $14.7B
    Feb 26, 2024
  • Holding
  • 226
    Aug 27, 2024
    More

  • 52-Week High/Low
  • $102.48 - $81.84
  • Turnover
  • 28.8%
  • Expense Ratio
  • 0.80%

Documents

Prospectus

Annual Reports

Performance

YTD

4.6%

3 Year

-7.29%

5 Year

24.29%

Best

51.99%

2000

Worst

-28.79%

2008

Alpha

PRHSX S&P 500

Chart +